Kaposi sarcoma-associated herpesvirus/human herpesvirus type 8 and Epstein-Barr virus in immunosuppressed renal transplant recipients.
Demirağ
A
A
Department of General Surgery, Faculty of Medicine, Baskent University, Ankara, Turkey.
Hizel
N
N
Karakayali
H
H
Moray
G
G
Akkoç
H
H
Bilgin
N
N
Haberal
M
M
D001379:Azathioprine / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006566:Herpesviridae Infections / Q000150:complications* / Q000175:diagnosis; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology*; D016133:Polymerase Chain Reaction; D012514:Sarcoma, Kaposi / Q000150:complications / Q000821:virology*; D013256:Steroids / Q000009:adverse effects; D013997:Time Factors
D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine